Clinical Trials Browser

Phase 2 × Liver Neoplasms × Epirubicin × Clear all

NCT00058487 2013-07-18

Epirubicin and Thalidomide in Treating Patients With Liver Cancer

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms